Efficacy and Safety of Fecal Microbiota Transplantation for Severe Clostridium Difficile Associated Colitis
Sponsor: Hadassah Medical Organization
Terminated
FMT for study indication has been permitted by Israeli Ministry of Health
Other terminated trials from Hadassah Medical Organization
This NA trial investigates Clostridium Difficile and is currently terminated or withdrawn. Hadassah Medical Organization leads this study, which shows 11 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 6 earlier versions
-
Sep 2019 — Jan 2021 [monthly]
Terminated NA
-
Apr 2019 — Sep 2019 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Mar 2019 — Apr 2019 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hadassah Medical Organization
For direct contact, visit the study record on ClinicalTrials.gov .